2JP2

Solution structure and resonance assignment of the N-terminal EVH1 domain from the human Spred2 protein (Sprouty-related protein with EVH1 domain isoform 2)

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1 mM [U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	0.05	6.0	ambient	298
2	3D CBCA(CO)NH	1 mM [U-100% 13C; U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	0.05	6.0	ambient	298
3	3D CBCANH	1 mM [U-100% 13C; U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	0.05	6.0	ambient	298
4	3D H(CCO)NH	1 mM [U-100% 13C; U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	0.05	6.0	ambient	298
5	3D C(CO)NH	1 mM [U-100% 13C; U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	0.05	6.0	ambient	298
6	3D HNCO	1 mM [U-100% 13C; U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	0.05	6.0	ambient	298
7	3D HCCH-TOCSY	1 mM [U-100% 13C; U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	100% D2O	0.05	6.0	ambient	298
8	3D HNHA	1 mM [U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	0.05	6.0	ambient	298
9	3D HNHB	1 mM [U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	0.05	6.0	ambient	298
10	2D 1H-1H TOCSY	1 mM [U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	100% D2O	0.05	6.0	ambient	298
11	2D DQF-COSY	1 mM [U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	100% D2O	0.05	6.0	ambient	298
12	2D 1H-1H NOESY	1 mM [U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	100% D2O	0.05	6.0	ambient	298
13	3D 1H-15N NOESY	1 mM [U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	0.05	6.0	ambient	298
14	3D 1H-13C NOESY	1 mM [U-100% 13C; U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	0.05	6.0	ambient	298
15	3D 1H-13C NOESY	1 mM [U-100% 13C; U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	100% D2O	0.05	6.0	ambient	298
16	2D 3JHNHa series	1 mM [U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	0.05	6.0	ambient	298
17	2D 15N T1 series	1 mM [U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	0.05	6.0	ambient	298
18	2D 15N T2 series	1 mM [U-100% 15N] Spred2 EVH1, 20 mM sodium phosphate, 50 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	0.05	6.0	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DRX	600
2	Bruker	DMX	750

NMR Refinement
Method	Details	Software
simulated annealing, molecular dynamics	Manual structure refinement, Refinement in explicit water	XWIN-NMR

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	XWIN-NMR	2.6	Bruker Biospin
2	data analysis	ANSIG	3.3	Kraulis
3	chemical shift assignment	ANSIG	3.3	Kraulis
4	peak picking	ANSIG	3.3	Kraulis
5	integration	ANSIG	3.3	Kraulis
6	data analysis	Azara	2.1	Boucher
7	peak picking	Azara	2.1	Boucher
8	refinement	PSVS	1.3	Hang, Montelione, et al.
9	structure validation	PSVS	1.3	Hang, Montelione, et al.
10	structure solution	X-PLOR NIH	2.14	Schwieters, Kuszewski, Tjandra and Clore
11	refinement	X-PLOR NIH	2.14	Schwieters, Kuszewski, Tjandra and Clore
12	structure solution	ARIA	1.2	Linge, O'Donoghue and Nilges
13	refinement	ARIA	1.2	Linge, O'Donoghue and Nilges

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.